Skip to main content

COVID-19 & cancer


12-01-2022 | COVID-19 | News

Antibody response to COVID-19 vaccine strengthened after third dose in cancer patients

Research from three countries adds support for the use of a booster dose of vaccines against SARS-CoV-2 in people with cancer, especially those undergoing active anticancer treatment.

03-11-2021 | COVID-19 | News

SARS-CoV-2 humoral, cellular immunity in people with cancer characterized

Two papers from the prospective, longitudinal UK CAPTURE consortium shed light on the humoral and cellular immune response to SARS-CoV-2 vaccination and infection in patients with cancer.

06-10-2021 | COVID-19 | News

CT analysis helps define COVID-19 vaccine-related axillary lymphadenopathy

An analysis of computed tomography scans from people with thoracic malignancies shows that approximately one in 11 people develop axillary lymphadenopathy following mRNA-based COVID-19 vaccination.

More on COVID-19 in cancer patients

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox

Image Credits